Amoy Diagnostics Co., Ltd. (300685.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 17.31

From 52W high−28.03%

Volume14.71M

Market capCNY 7.18B

P/E (TTM)19.9x

P/S (TTM)6.0x

Div yield2.47%

Key dataSep 18, 2026

Open

CNY 17.31

From 52W high

−28.03%

Volume

14.71M

Market cap

CNY 7.18B

ValuationView details →

P/E (Fwd)

18.6x

EV/EBITDA

13.2x

P/E (TTM)

19.9x

RSI (14)

58.6

MomentumView details →

1D Return

−3.05%

YTD Return

−11.00%

ValuationView details →

P/E (Fwd)

18.6x

P/E (TTM)

19.9x

EV/EBITDA

13.2x

EV/Sales

5.3x

P/S (TTM)

6.0x

P/B (TTM)

3.9x

ProfitabilityView details →

Gross Margin

82.36%

Net Margin

30.01%

EBITDA Margin

39.76%

ROE (TTM)

17.30%

ROA (TTM)

14.85%

Asset Turnover

0.50x

GrowthView details →

Revenue YoY

+3.33%

EPS YoY

+28.07%

FCF YoY

−7.67%

Revenue CAGR 3Y

+12.46%

EPS CAGR 3Y

+10.74%

EBITDA YoY

—

MomentumView details →

1D Return

−3.05%

YTD Return

−11.00%

1Y Return

−19.78%

RSI (14)

58.6

vs 50D SMA

+2.35%

vs 200D SMA

−8.71%

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

15.14x

Quick Ratio

14.81x

Div Yield

2.47%

Div Rate

CNY 0.45

Div Growth 1Y

+50.00%

EarningsView details →

EPS (Actual)

CNY 0.20

EPS Surprise

−4.76%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.21

Avg Surprise (4Q)

−4.76%

Rev Surprise

−15.18%

Financials snapshotView financials →

Revenue (TTM)

1.19B

Net Income (TTM)

355.94M

Op. CF (TTM)

368.86M

Next earningsOct 27, 2026 →

Latest newsMore news →

Amoy Diagnostics directors and executives, including general manager Luo Jiemin, plan to increase their holdings of the company's shares by up to RMB 10 million in aggregate within three months of the announcement.5d ago

Amoy Diagnostics announced that it has repurchased 9.1193 million shares for about 171 million yuan under its buyback program to cancel shares and reduce registered capital.20d ago

Similar companies

沧州明珠002108.SZ 莱宝高科002106.SZ 四会富仕300852.SZ 三钢闽光002110.SZ 聚灿光电300708.SZ 香山股份002870.SZ Find similar companies →

Latest newsMore news →

Amoy Diagnostics directors and executives, including general manager Luo Jiemin, plan to increase their holdings of the company's shares by up to RMB 10 million in aggregate within three months of the announcement.5d ago Amoy Diagnostics announced that it has repurchased 9.1193 million shares for about 171 million yuan under its buyback program to cancel shares and reduce registered capital.20d ago